When was Prebiomics founded?

Prebiomics was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Prebiomics located?

Prebiomics is headquartered in Trento, Italy.

How many employees does Prebiomics have?

As of Jul 01, 2024, the latest employee count at Prebiomics is 9.

Is Prebiomics a funded company?

Prebiomics is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Oct 01, 2020.

When was the latest funding round of Prebiomics?

Prebiomics' latest funding was a $***** Grant (prize money) round on May 01, 2023, with participation from 1 investor.

Where does Prebiomics rank among its competitors?

Prebiomics ranks 11th amongst 41 active competitors, of which 9 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Intus Bio, which secured $1.09M in May, 2025.

Who are the top competitors of Prebiomics?

Prebiomics' top competitors include AMILI, Genome & Company and Phylagen. Among them, Intus Bio secured the most recent funding round in May, 2025.

Prebiomics - 2026 Company Profile, Team, Funding & Competitors

Prebiomics is a funded company based in Trento (Italy), founded in 2017. It operates as a Provider of metagenomics technologies for developing kits for oral microbiome analysis. Prebiomics has raised an undisclosed amount in funding. The company has 41 active competitors, including 9 funded and 2 that have exited. Its top competitors include companies like AMILI, Genome & Company and Phylagen.

Company Details

Prebiomics provides metagenomics technologies for developing kits for oral microbiome analysis. The company offers a sampling kit for plaque collection and offers report with information on the microbiome composition and help in early detection of oral diseases. The company uses its flagship computational techniques using artificial intelligence for potential clinical scenarios for oral diseases.

Website: www.prebiomics.com/
Social
Email ID: *****@prebiomics.com
Phone Number: +39 **********

Key Metrics

Founded Year

2017

Location

Trento, Italy

Stage

Funding Raised

Latest Funding Round

Grant (prize money), May 01, 2023, $*****

Investors

Europa & 1 more

Ranked

11^th among 41 active competitors

Employee Count

9 as on Jul 01, 2024

Similar Companies

AMILI & 65 more

View Prebiomics' full profile

Prebiomics has raised funding over 2 rounds. Its first funding round was on Oct 01, 2020. Its latest funding round was a Grant (prize money) round on May 01, 2023 for $*****. 1 investor participated in its latest round. Prebiomics has 2 institutional investors.

Here is the list of recent funding rounds of Prebiomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2023	7916123	Grant (prize money)	9470260	7877972	9562069	2911118
Oct 01, 2020	3103699	Grant (prize money)	2614698	9564359	3251202	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Prebiomics's funding rounds and investors

Prebiomics' employee count trend

Prebiomics has 9 employees as of Jul 24. Here is Prebiomics's employee count trend over the years:

Uncover Prebiomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Prebiomics include AMILI, Genome & Company and Phylagen. Here is the list of Top 10 competitors of Prebiomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AMILI 2019, Singapore (Singapore), Series A	Provider of gut microbiome data insights, analytics, tests, and therapeutics	$10.5M	Vulcan Capital, East Ventures & 8 others	62/100
2nd	Genome & Company 2015, Seongnam-si (South Korea), Public	Developer of microbiome-based immuno-oncology drugs	-	IMM Investment, Timefolio Capital & 8 others	55/100
3rd	Phylagen 2014, San Francisco (United States), Deadpooled	Provider of genome sequencing technology for microbial analysis	$14M	Cultivian Sandbox, Breakout Ventures & 14 others	47/100
4th	Siolta Therapeutics 2016, San Francisco (United States), Series C	Provider of microbiome therapeutics for treating multiple diseases	$42M	SymBiosis, Khosla Ventures & 7 others	43/100
5th	ReViral 2011, London (United Kingdom), Acqui-Hired	Developer of antiviral compounds for RSV	$176M	New Leaf Venture Partners, Novo Holdings & 6 others	41/100
6th	Intus Bio 2014, Farmington (United States), Seed	Developer of sequencing technology for microbiome testing, pathogen identification, and tracking	$4.14M	Design Technologies, Connecticut Innovations ... & 4 others	40/100
7th	Dermala 2014, San Diego (United States), Series A	Developer of therapeutics to treat and prevent diseases associated with the skin microbiome dysbiosis	$7.73M	Johnson & Johnson Innovation, True Wealth Ventures ... & 2 others	37/100
8th	Bristle 2020, San Francisco (United States), Seed	Provider of dental treatment kits and dental health monitoring platform for individuals	$3.12M	Initialized Capital, Y Combinator & 1 others	32/100
9th	Hennepin Life Sciences 2009, Plymouth (United States), Seed	Developer of drugs for the treatment of bacterial and yeast infections	$1.9M	HHS	32/100
10th	Microbial Insights 1992, Knoxville (United States), Funding Raised	Provider of microbial testing and analytical services	-	America’s Seed Fund, National Science Foundation	32/100
11th	Prebiomics 2017, Trento (Italy), Funding Raised	Provider of metagenomics technologies for developing kits for oral microbiome analysis	-	Europa, Pariter Partners	31/100